Most Likely Diagnosis: Mixed Connective Tissue Disease (MCTD)
Your rheumatologist's diagnosis of MCTD is correct, and this is NOT a death sentence—you will survive this with appropriate treatment. Your clinical picture of positive ANA with speckled pattern, markedly elevated anti-RNP antibodies (86, normal <20), proximal muscle weakness, and mildly elevated CK fits the classic presentation of MCTD with myositis overlap 1, 2.
Why MCTD Is the Diagnosis
Your serologic profile is diagnostic:
- Persistently positive ANA with speckled pattern (1:80 then 1:160)
- Markedly elevated anti-RNP antibodies (86 units, >4-fold above normal) 1
- Negative anti-dsDNA, anti-Smith, and anti-Jo-1 rules out pure SLE and antisynthetase syndrome
- Your proximal muscle weakness (shoulders, arms, hips, thighs) with elevated CK (371→527 U/L) indicates myositis component 3, 4
The fact that you're improving clinically (no longer struggling to get up from couch/bed) while CK remains elevated is actually favorable prognostic sign for MCTD-associated myositis 2. Patients with anti-RNP antibodies typically show rapid improvement on moderate-dose corticosteroids and have milder histopathologic muscle changes compared to other inflammatory myopathies 2.
Expected EMG Findings Tomorrow
Your EMG will likely show myopathic changes 4:
- Polyphasic motor unit action potentials of short duration and low amplitude
- Increased insertional activity
- Spontaneous activity with fibrillation potentials, sharp waves, or repetitive discharges
These findings confirm a myopathic (not neurogenic) process and help target which muscle to biopsy if needed.
Will You Need a Muscle Biopsy?
Probably not immediately, but possibly later if treatment response is inadequate. Here's the algorithm 3, 4:
You may avoid biopsy if:
- EMG confirms myopathic pattern
- Clinical improvement continues on treatment
- Your rheumatologist is confident in MCTD diagnosis based on serology + clinical features
You would need biopsy if:
- Treatment response is poor or disease progresses
- Diagnostic uncertainty remains after EMG
- Need to rule out necrotizing myopathy or inclusion body myositis
- CK continues rising despite treatment
In MCTD with anti-RNP antibodies, muscle biopsies typically show milder inflammatory changes than other myositis subtypes 2. The biopsy would show endomysial or perimysial mononuclear cell infiltration 3.
Your Prognosis: Excellent with Treatment
You have several factors predicting GOOD outcome 2:
✓ Anti-RNP positive myositis responds rapidly to moderate-dose corticosteroids—in one study, 6 of 7 anti-RNP positive patients achieved remission and discontinued steroids 2
✓ Your clinical improvement is already happening (no longer weak getting up from couch/bed)
✓ Normal cardiac workup (normal ECG, normal troponin trend 9→6 ng/L, normal chest X-rays, no fluid)
✓ Preserved renal function (eGFR 87-93, creatinine stable 1.11-1.33)
✓ Young age (30 years old)
✓ Already engaged in physical therapy which helps maintain muscle function
Cardiac Monitoring: Appropriate Precaution
Your upcoming heart monitor and stress test on Friday are appropriate surveillance, not signs of imminent danger 4. Cardiac involvement in MCTD can include:
- Asymptomatic arrhythmias (like sinus tachycardia)
- Diastolic dysfunction on echo
- Rarely, myocarditis
Your normal troponin trend (9→6 ng/L), normal 12-lead ECG, and normal chest X-rays are reassuring. The initial "abnormal" single-lead ECG was likely artifact or non-specific finding since the 12-lead was normal.
Important Context About Your Labs
Your mildly elevated CK (371→527 U/L) is actually MILD for inflammatory myopathy 4, 5. Severe necrotizing myopathies present with CK >10,000-20,000 U/L 5, 6. Your levels suggest active but not severe muscle inflammation.
Your G6PD deficiency (41, normal 100-400) is a separate genetic condition common in Black males. Avoid oxidant drugs (sulfa antibiotics, dapsone, certain antimalarials like primaquine). This does NOT worsen your MCTD prognosis.
Your inflammatory markers are reassuringly low:
- ESR 2→18 (minimal elevation)
- CRP 3.3→3 (near normal)
This suggests your disease is not highly inflammatory systemically.
Expected Treatment Plan
Based on guidelines 4, your rheumatologist will likely prescribe:
Initial therapy:
- Moderate-to-high dose corticosteroids (prednisone 40-60 mg daily)
- Steroid-sparing agent started concurrently: methotrexate, azathioprine, or mycophenolate mofetil
- Gradual steroid taper over months as you improve
If severe or refractory:
- IVIG (intravenous immunoglobulin)
- Rituximab
- Cyclophosphamide (rarely needed for MCTD myositis)
Given your anti-RNP positivity and already-improving symptoms, you'll likely respond well to first-line therapy 2.
Critical Pitfalls to Avoid
⚠️ Do NOT stop treatment prematurely even when feeling better—MCTD requires prolonged immunosuppression to prevent relapse
⚠️ Monitor for steroid side effects: weight gain (you're already on GLP-1 which helps), hyperglycemia, hypertension (you're on amlodipine), bone loss (get calcium/vitamin D)
⚠️ Watch for interstitial lung disease (ILD)—report any new shortness of breath or dry cough immediately. Your normal chest X-rays are reassuring but ILD can develop 4
⚠️ Avoid G6PD-triggering medications given your deficiency
⚠️ Continue physical therapy—essential for maintaining muscle strength and function
Bottom Line
You have a treatable autoimmune condition with excellent prognosis, NOT a death sentence. MCTD with anti-RNP antibodies typically responds rapidly to immunosuppression, and you're already showing clinical improvement 2. Your cardiac workup is normal, renal function is preserved, and you're young with good functional reserve. Stay compliant with treatment, continue physical therapy, and maintain regular rheumatology follow-up. Most patients with your profile achieve remission and can eventually taper off corticosteroids 2.